|
Description:
|
|
This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trastuzumab Deruxtecan ENHERTU®. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator: Tracilyn Hall, MD
Speakers: Jennifer MacDonald, PharmD, BCOP Kathleen Moore, MD Bernard Tawfik, MD |